The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Beta-galactosidase-Global Market Insights and Sales Trends 2025
Synopsis
β-Galactosidase is a glycoside hydrolase enzyme that catalyzes hydrolysis of terminal non-reducing β-D-galactose residues in β-D-galactosides.
The global Beta-galactosidase market size is expected to reach US$ 1360.9 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Beta-galactosidase in various end use industries. The expanding demands from the Food industry, Pharmaceutical industry and Others,, are propelling Beta-galactosidase market. Neutral Type, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Acid Type segment is estimated at % CAGR for the next seven-year period.
Neutral lactase the largest segment, with a share over 80%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Beta-galactosidase, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Beta-galactosidase market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Beta-galactosidase market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Beta-galactosidase sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Beta-galactosidase covered in this report include DSM, Novozymes, DuPont, Chr. Hansen Holding, Amano Enzyme, Enzyme Development, SternEnzym, Specialty Enzymes & Biotechnologies and Enzyme Solutions, etc.
The global Beta-galactosidase market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
DSM
Novozymes
DuPont
Chr. Hansen Holding
Amano Enzyme
Enzyme Development
SternEnzym
Specialty Enzymes & Biotechnologies
Enzyme Solutions
Advanced Enzymes
Zhongnuo BioTech
Enze Bio
Meihua BioTech
Kono Chem
Global Beta-galactosidase market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Beta-galactosidase market, Segment by Type:
Neutral Type
Acid Type
Global Beta-galactosidase market, by Application
Food industry
Pharmaceutical industry
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Beta-galactosidase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Beta-galactosidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
β-Galactosidase is a glycoside hydrolase enzyme that catalyzes hydrolysis of terminal non-reducing β-D-galactose residues in β-D-galactosides.
The global Beta-galactosidase market size is expected to reach US$ 1360.9 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Beta-galactosidase in various end use industries. The expanding demands from the Food industry, Pharmaceutical industry and Others,, are propelling Beta-galactosidase market. Neutral Type, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Acid Type segment is estimated at % CAGR for the next seven-year period.
Neutral lactase the largest segment, with a share over 80%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Beta-galactosidase, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Beta-galactosidase market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Beta-galactosidase market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Beta-galactosidase sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Beta-galactosidase covered in this report include DSM, Novozymes, DuPont, Chr. Hansen Holding, Amano Enzyme, Enzyme Development, SternEnzym, Specialty Enzymes & Biotechnologies and Enzyme Solutions, etc.
The global Beta-galactosidase market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
DSM
Novozymes
DuPont
Chr. Hansen Holding
Amano Enzyme
Enzyme Development
SternEnzym
Specialty Enzymes & Biotechnologies
Enzyme Solutions
Advanced Enzymes
Zhongnuo BioTech
Enze Bio
Meihua BioTech
Kono Chem
Global Beta-galactosidase market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Beta-galactosidase market, Segment by Type:
Neutral Type
Acid Type
Global Beta-galactosidase market, by Application
Food industry
Pharmaceutical industry
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Beta-galactosidase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Beta-galactosidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Beta-galactosidase Market Overview
1.1 Beta-galactosidase Product Overview
1.2 Beta-galactosidase Market Segment by Type
1.2.1 Neutral Type
1.2.2 Acid Type
1.3 Global Beta-galactosidase Market Size by Type
1.3.1 Global Beta-galactosidase Market Size Overview by Type (2018-2029)
1.3.2 Global Beta-galactosidase Historic Market Size Review by Type (2018-2023)
1.3.3 Global Beta-galactosidase Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Beta-galactosidase Sales Breakdown by Type (2018-2023)
1.4.2 Europe Beta-galactosidase Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Beta-galactosidase Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Beta-galactosidase Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Beta-galactosidase Sales Breakdown by Type (2018-2023)
2 Global Beta-galactosidase Market Competition by Company
2.1 Global Top Players by Beta-galactosidase Sales (2018-2023)
2.2 Global Top Players by Beta-galactosidase Revenue (2018-2023)
2.3 Global Top Players by Beta-galactosidase Price (2018-2023)
2.4 Global Top Manufacturers Beta-galactosidase Manufacturing Base Distribution, Sales Area, Product Type
2.5 Beta-galactosidase Market Competitive Situation and Trends
2.5.1 Beta-galactosidase Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Beta-galactosidase Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Beta-galactosidase as of 2022)
2.7 Date of Key Manufacturers Enter into Beta-galactosidase Market
2.8 Key Manufacturers Beta-galactosidase Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Beta-galactosidase Status and Outlook by Region
3.1 Global Beta-galactosidase Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Beta-galactosidase Historic Market Size by Region
3.2.1 Global Beta-galactosidase Sales in Volume by Region (2018-2023)
3.2.2 Global Beta-galactosidase Sales in Value by Region (2018-2023)
3.2.3 Global Beta-galactosidase Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Beta-galactosidase Forecasted Market Size by Region
3.3.1 Global Beta-galactosidase Sales in Volume by Region (2024-2029)
3.3.2 Global Beta-galactosidase Sales in Value by Region (2024-2029)
3.3.3 Global Beta-galactosidase Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Beta-galactosidase by Application
4.1 Beta-galactosidase Market Segment by Application
4.1.1 Food industry
4.1.2 Pharmaceutical industry
4.1.3 Others
4.2 Global Beta-galactosidase Market Size by Application
4.2.1 Global Beta-galactosidase Market Size Overview by Application (2018-2029)
4.2.2 Global Beta-galactosidase Historic Market Size Review by Application (2018-2023)
4.2.3 Global Beta-galactosidase Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Beta-galactosidase Sales Breakdown by Application (2018-2023)
4.3.2 Europe Beta-galactosidase Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Beta-galactosidase Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Beta-galactosidase Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Beta-galactosidase Sales Breakdown by Application (2018-2023)
5 North America Beta-galactosidase by Country
5.1 North America Beta-galactosidase Historic Market Size by Country
5.1.1 North America Beta-galactosidase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Beta-galactosidase Sales in Volume by Country (2018-2023)
5.1.3 North America Beta-galactosidase Sales in Value by Country (2018-2023)
5.2 North America Beta-galactosidase Forecasted Market Size by Country
5.2.1 North America Beta-galactosidase Sales in Volume by Country (2024-2029)
5.2.2 North America Beta-galactosidase Sales in Value by Country (2024-2029)
6 Europe Beta-galactosidase by Country
6.1 Europe Beta-galactosidase Historic Market Size by Country
6.1.1 Europe Beta-galactosidase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Beta-galactosidase Sales in Volume by Country (2018-2023)
6.1.3 Europe Beta-galactosidase Sales in Value by Country (2018-2023)
6.2 Europe Beta-galactosidase Forecasted Market Size by Country
6.2.1 Europe Beta-galactosidase Sales in Volume by Country (2024-2029)
6.2.2 Europe Beta-galactosidase Sales in Value by Country (2024-2029)
7 Asia-Pacific Beta-galactosidase by Region
7.1 Asia-Pacific Beta-galactosidase Historic Market Size by Region
7.1.1 Asia-Pacific Beta-galactosidase Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Beta-galactosidase Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Beta-galactosidase Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Beta-galactosidase Forecasted Market Size by Region
7.2.1 Asia-Pacific Beta-galactosidase Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Beta-galactosidase Sales in Value by Region (2024-2029)
8 Latin America Beta-galactosidase by Country
8.1 Latin America Beta-galactosidase Historic Market Size by Country
8.1.1 Latin America Beta-galactosidase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Beta-galactosidase Sales in Volume by Country (2018-2023)
8.1.3 Latin America Beta-galactosidase Sales in Value by Country (2018-2023)
8.2 Latin America Beta-galactosidase Forecasted Market Size by Country
8.2.1 Latin America Beta-galactosidase Sales in Volume by Country (2024-2029)
8.2.2 Latin America Beta-galactosidase Sales in Value by Country (2024-2029)
9 Middle East and Africa Beta-galactosidase by Country
9.1 Middle East and Africa Beta-galactosidase Historic Market Size by Country
9.1.1 Middle East and Africa Beta-galactosidase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Beta-galactosidase Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Beta-galactosidase Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Beta-galactosidase Forecasted Market Size by Country
9.2.1 Middle East and Africa Beta-galactosidase Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Beta-galactosidase Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 DSM
10.1.1 DSM Company Information
10.1.2 DSM Introduction and Business Overview
10.1.3 DSM Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.1.4 DSM Beta-galactosidase Products Offered
10.1.5 DSM Recent Development
10.2 Novozymes
10.2.1 Novozymes Company Information
10.2.2 Novozymes Introduction and Business Overview
10.2.3 Novozymes Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novozymes Beta-galactosidase Products Offered
10.2.5 Novozymes Recent Development
10.3 DuPont
10.3.1 DuPont Company Information
10.3.2 DuPont Introduction and Business Overview
10.3.3 DuPont Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.3.4 DuPont Beta-galactosidase Products Offered
10.3.5 DuPont Recent Development
10.4 Chr. Hansen Holding
10.4.1 Chr. Hansen Holding Company Information
10.4.2 Chr. Hansen Holding Introduction and Business Overview
10.4.3 Chr. Hansen Holding Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chr. Hansen Holding Beta-galactosidase Products Offered
10.4.5 Chr. Hansen Holding Recent Development
10.5 Amano Enzyme
10.5.1 Amano Enzyme Company Information
10.5.2 Amano Enzyme Introduction and Business Overview
10.5.3 Amano Enzyme Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Amano Enzyme Beta-galactosidase Products Offered
10.5.5 Amano Enzyme Recent Development
10.6 Enzyme Development
10.6.1 Enzyme Development Company Information
10.6.2 Enzyme Development Introduction and Business Overview
10.6.3 Enzyme Development Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Enzyme Development Beta-galactosidase Products Offered
10.6.5 Enzyme Development Recent Development
10.7 SternEnzym
10.7.1 SternEnzym Company Information
10.7.2 SternEnzym Introduction and Business Overview
10.7.3 SternEnzym Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.7.4 SternEnzym Beta-galactosidase Products Offered
10.7.5 SternEnzym Recent Development
10.8 Specialty Enzymes & Biotechnologies
10.8.1 Specialty Enzymes & Biotechnologies Company Information
10.8.2 Specialty Enzymes & Biotechnologies Introduction and Business Overview
10.8.3 Specialty Enzymes & Biotechnologies Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Specialty Enzymes & Biotechnologies Beta-galactosidase Products Offered
10.8.5 Specialty Enzymes & Biotechnologies Recent Development
10.9 Enzyme Solutions
10.9.1 Enzyme Solutions Company Information
10.9.2 Enzyme Solutions Introduction and Business Overview
10.9.3 Enzyme Solutions Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Enzyme Solutions Beta-galactosidase Products Offered
10.9.5 Enzyme Solutions Recent Development
10.10 Advanced Enzymes
10.10.1 Advanced Enzymes Company Information
10.10.2 Advanced Enzymes Introduction and Business Overview
10.10.3 Advanced Enzymes Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Advanced Enzymes Beta-galactosidase Products Offered
10.10.5 Advanced Enzymes Recent Development
10.11 Zhongnuo BioTech
10.11.1 Zhongnuo BioTech Company Information
10.11.2 Zhongnuo BioTech Introduction and Business Overview
10.11.3 Zhongnuo BioTech Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Zhongnuo BioTech Beta-galactosidase Products Offered
10.11.5 Zhongnuo BioTech Recent Development
10.12 Enze Bio
10.12.1 Enze Bio Company Information
10.12.2 Enze Bio Introduction and Business Overview
10.12.3 Enze Bio Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Enze Bio Beta-galactosidase Products Offered
10.12.5 Enze Bio Recent Development
10.13 Meihua BioTech
10.13.1 Meihua BioTech Company Information
10.13.2 Meihua BioTech Introduction and Business Overview
10.13.3 Meihua BioTech Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Meihua BioTech Beta-galactosidase Products Offered
10.13.5 Meihua BioTech Recent Development
10.14 Kono Chem
10.14.1 Kono Chem Company Information
10.14.2 Kono Chem Introduction and Business Overview
10.14.3 Kono Chem Beta-galactosidase Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Kono Chem Beta-galactosidase Products Offered
10.14.5 Kono Chem Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Beta-galactosidase Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Beta-galactosidase Industrial Chain Analysis
11.4 Beta-galactosidase Market Dynamics
11.4.1 Beta-galactosidase Industry Trends
11.4.2 Beta-galactosidase Market Drivers
11.4.3 Beta-galactosidase Market Challenges
11.4.4 Beta-galactosidase Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Beta-galactosidase Distributors
12.3 Beta-galactosidase Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
